<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">4451</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> http://dx.doi.org/10.31782/IJCRR.2022.14902</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Predicted Interactions of Cyclooxygenase2 with Nasopharyngeal Cancer-linked Ribosomal Proteins, uS19 and eL27&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Shamsuri</surname><given-names>Alyaa Syafiqah Binti</given-names></name></contrib><contrib contrib-type="author"><name><surname>Sim</surname><given-names>Edmund Ui-Hang</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>3</day><month>05</month><year>2022</year></pub-date><volume>)</volume><issue/><fpage>7</fpage><lpage>13</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Introduction: The Cyclooxygenase 2 (COX-2) and ribosomal proteins (RP) of uS19 and eL27 were reported to be associated with nasopharyngeal cancer (NPC). However, there is no studies on their interactions. Objective/Aim: This study aimed to extrapolate the interactions of COX-2 with uS19 and eL27 via in silico approach. Methods: Bioinformatics analysis involving the web-based applications of SWISS-MODEL, ClusPro, FireDock/PatchDock and Protein Interaction Calculator (PIC), and the UniProtKB database were used for the purpose of our study. Results: We revealed possible interactions between uS19 and eL27 with COX-2 individually. Evaluation of the interacting inter-face amino acid residues of the uS19-COX2 and eL27-COX2 complexes show hydrophobic and ionic bonds in the former and only hydrophobic bonds in the latter. Conclusion: Our findings provide novel in silico evidence of COX-2__ampersandsignrsquo;s interactions with two NPC-associated RPs (uS19 and eL27), and propose an interplay among these proteins during the oncogenesis of NPC.&#13;
</p></abstract><kwd-group><kwd>Cyclooxygenase 2</kwd><kwd> Nasopharyngeal carcinoma</kwd><kwd> Molecular docking</kwd><kwd> Protein-protein interaction</kwd><kwd> Ribosomal proteins</kwd><kwd>  uS19 (S15)</kwd><kwd> eL27 (L27)</kwd></kwd-group></article-meta></front></article>
